NIH-funded research R01 grant

MOMs Program: Integrated Maternal Care to Reduce Severe Maternal Morbidity

Official title: Maternal OutcoMes (MOMs) Program: Testing Integrated Maternal Care Model Approaches to Reduce Risk of Severe Maternal Morbidity

Funded at Feinstein Institute for Medical Research · NIH-11381203 · Data updated 2026-11-12

A program tested at delivery and early pregnancy to help high-risk Black and Hispanic patients get timely, appropriate care to reduce serious pregnancy complications.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionFeinstein Institute for Medical Research
NIH-funded
Lab location1 site (Manhasset, United States)
Project startSeptember 22, 2023
Project endJune 30, 2028
Funding year2026
Award (this year)$775,906
NIH project number5R01NR021134-04
Project IDNIH-11381203 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants are Black or Hispanic pregnant patients with obstetric comorbidity index ≥2 or a history of pre-eclampsia who are receiving care at participating sites.

Less likely to help

Patients not meeting risk criteria or not receiving care at participating sites may have limited direct benefit.

What this research studies

This project tests an integrated care model delivered at two levels of intensity to support pregnant patients who are at high risk for severe maternal morbidity. It builds on the MOMs program, which has shown a large drop in hospital readmissions for Black patients within 30 days after birth, and now aims to see if expanding to prenatal periods is effective. The study will involve an AI-enabled support tool to address needs like transportation, food insecurity, and housing, while coordinating care with clinical staff. By focusing on Black and Hispanic pregnant people with certain risk factors, the trial seeks to improve outcomes during pregnancy and after delivery.

Why it matters

Potential benefit: If successful, the program could reduce severe pregnancy complications and improve overall health for high-risk mothers and babies.

How similar studies have gone: Preliminary MOMs data from 2,500 participants suggested a substantial reduction in SMM-related hospital admissions within 30 days after delivery among Black patients.

Where this research is happening

  • Feinstein Institute for Medical Research
    Manhasset, United States
    Active

Researchers

  • Principal investigator: Fitzpatrick, Stephanie Lenay — Feinstein Institute for Medical Research
  • Study coordinator: Fitzpatrick, Stephanie Lenay

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.